SELLAS Life Sciences Group, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $4.5M | $37.1M | $23.7M |
| FY2015 | $0 | $-12.3M | $1.4M |
| FY2016 | — | $-5.0M | $6.0M |
| FY2017 | $2.6M | $2.1M | $2.3M |
| FY2018 | $0 | $5.2M | $5.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $4.5M | $37.1M | $23.7M |
| FY2015 | $0 | $-12.3M | $1.4M |
| FY2016 | — | $-5.0M | $6.0M |
| FY2017 | $2.6M | $2.1M | $2.3M |
| FY2018 | $0 | $5.2M | $5.3M |